Inactive Instrument

News Sophiris Bio

Equities

SPHS

CA83578Q2099

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Swiss franc rises to six year high as central bank stands back	21-11-30	RE
Sophiris Bio : Swiss c.bank diverges from peers to stick with ultra-loose monetary course	21-09-23	RE
Transcript : Sophiris Bio, Inc. - Special Call	19-06-19
Transcript : Sophiris Bio, Inc. - Special Call	18-12-17
Sophiris Bio : Reports Fourth Quarter and Full Year 2016 Financial Results and Key Corporate Highlights	17-03-27	PU
Sophiris Bio : Reports Second Quarter 2016 Financial Results and Key Business Highlights	16-08-09	PU
Sophiris Bio : Reports First Quarter 2016 Financial Results and Key Business Highlights	16-05-16	PU
Sophiris Bio : To Present Topsalysin Phase 3 Data from Positive PLUS-1 Study as a Late Breaking Poster During the 111th American Urological Association Annual Meeting	16-05-05	PU
Sophiris Bio, Inc. Announces Joseph L. Turner Would Not Be Stand for Re-Election at the Annual General Meeting	16-04-29	CI
Sophiris Bio, Inc. Auditor Raises 'Going Concern' Doubt	16-03-28	CI
Sophiris Bio, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2015	16-03-23	CI
Sophiris Bio, Inc. Reports Encouraging Preliminary Data from Phase 2A Proof of Concept Study in Localized Prostate Cancer	16-01-28	CI
Sophiris Bio, Inc. announced that it has received $2.8 million in funding from Aspire Capital Partners, LLC	15-12-30	CI
Sophiris Bio : Reports Third Quarter Financial Results and Business Highlights	15-12-09	PU
Sophiris Bio : Phase 3 BPH Study Successfully Meets Primary Endpoint	15-12-09	PU
Sophiris Bio, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015	15-11-16	CI
Sophiris Bio Phase 3 BPH Study Successfully Meets Primary Endpoint	15-11-10	CI
Sophiris Bio : Reports Second Quarter Financial Results	15-08-13	BU
Sophiris Bio, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015	15-08-13	CI
Sophiris Bio : to Present at the LD Micro Invitational Conference	15-05-27	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sophiris Bio

Equities

SPHS

CA83578Q2099

Summary

Filters